Development and Optimization of Fluvastatin Sodium Loaded Biodegradable Microspheres
Abstract
Fluvastatin sodium is a hypolipidemic agent that reduces cholesterol synthesis by inhibiting HMG-CoA reductase. The drug has a comparatively short biological half-life (1.2 hours) and low bioavailability (24–29%), making it an appropriate candidate for a sustained-release drug delivery system. This study aimed to formulate biodegradable microspheres of fluvastatin sodium by optimization through an experimental design approach. Microspheres containing fluvastatin sodium were prepared by o/w emulsification solvent evaporation method using poly (lactic-co-glycolic acid) (PLGA 50:50) as a biodegradable polymer. 32 full factorial design was applied to study the effect of drug to polymer ratio and stirring speed on dependent variables, i.e. particle size, entrapment efficiency, Q1h, t80%. Prepared formulations were subjected to evaluate physicochemical properties and release characteristics. DSC and FTIR proved no interaction between the drug and excipients. Microspheres possessed size in the range of 193 to 344 μm and entrapment efficiency varied from 63.1 to 85.6%. Formulations showed drug release up to 23% within 1-hour. while t80% was found in between 3–9 hours. Regression analysis and ANOVA results suggested a significant effect (p<0.05) of variables on responses. The results of the present study suggested that biodegradable microspheres of fluvastatin sodium prepared using poly (lactic-co-glycolic acid) can be a promising alternative for conventional delivery and suitable for sustained drug release.
Keywords:
Biodegradable microspheres, emulsion solvent evaporation, fluvastatin sodium, full factorial design, PLGADOI
https://doi.org/10.25004/IJPSDR.2023.150402References
Dey S, Pramanik S, Malgope A. Formulation and optimization of sustained release Stavudine microspheres using response surface methodology. ISRN Pharm. 2011; 627623.
Fukuda IM, Pinto Camila FF, Moreira¬ CS, Saviano AM, Lourenço FR. Design of Experiments (DoE) applied to pharmaceutical and analytical Quality by Design (QbD). Braz J Pharm Sci. 2018; 54(spe):e01006.
Grandhi S, Avula PR. Aqueous-core nanocapsules of lamivudine: optimization by design of experiments. Asian J Pharm. 2019; 13:318-327.
Kharb V, Saharan VA, Dev K, Jadhav H, Purohit S. Formulation, evaluation and 3(2) full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres. Pharm Dev Technol. 2014; 19:839-852.
Anwer MK, Mohammad M, Iqbal M, Ansari MN, Ezzeldin E, Fatima F, Alshahrani SM, Aldawsari MF, Alalaiwe A, Alzahrani AA, Aldayel AM. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect. J Thromb Thrombolysis. 2020; 49:404–412.
Al-Hashimi N, Begg N, Alany RG, Hassanin H, Elshaer A. Oral modified release multiple-unit particulate systems: compressed pellets, microparticles and nanoparticles. Pharmaceutics. 2018; 10:176.
Howick K, Alam R, Chruscicka B, Kandil D, Fitzpatrick D, Ryan AM, Cryan JF, Schellekens H, Griffin BT. Sustained-release multiparticulates for oral delivery of a novel peptidic ghrelin agonist: Formulation design and in vitro characterization. Int J Pharm. 2018; 536:63-72.
Dey NS, Majumdar S, Rao MEB. Multiparticulate drug delivery systems for controlled release. Tropical J Pharm Res. 2008; 7:1067-1075.
Prajapati VD, Jani GK, Kapadia JR. Current knowledge on biodegradable microspheres in drug delivery. Expert Opin Drug Deliv. 2015; 12:1283-1299.
Prajapati SK, Jain A, Jain A, Jain S. Biodegradable polymers and constructs: A novel approach in drug delivery. Eur Polymer J. 2019; 120:109191.
Okada H, Toguchi H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst. 1995; 12:1-99.
Lagreca E, Onesto V, Di Natale C, La Manna S, Netti PA, Vecchione R. Recent advances in the formulation of PLGA microparticles for controlled drug delivery. Prog Biomater. 2020; 9:153–174.
Chereddy KK, Valéry LP, Véronique P. PLGA: From a classic drug carrier to a novel therapeutic activity contributor. J Control Rel. 2018; 289:10-13.
Bee S, Abdul Hamid ZA, Mariatti M, Yahaya BH, Lim K, Bee ST, Sin L. Approaches to improve therapeutic efficacy of biodegradable PLA/PLGA microspheres: a review. Polymer Rev. 2018; 58:495-536.
G€opferich RA. Mechanisms of polymer degradation and erosion. Biomaterials. 1996; 17:103–114.
Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems-A review. Int J Pharm. 2011; 415:34–52.
Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011; 3:1377-1397.
Geevarghese R, Shirolkar S. Formulation and evaluation of fluvastatin sodium drug-in-adhesive transdermal system. J Res Pharm. 2020; 24:562-571.
Shah D, Sorathia K. Design and evaluation of sustained release spherical agglomerates of Fluvastatin sodium by crystallo-co-agglomeration. J Appl Pharm Sci. 2017; 7:99-108.
Soni G, Yadav KS, Gupta MK. Design of experiments (DoE) approach to optimize the sustained release microparticles of gefitinib. Curr Drug Deliv. 2019; 16:364-374.
Soppimath KS, Kulkarni AR, Aminabhavi TM, Bhaskar C. Cellulose acetate microspheres prepared by o/w emulsification and solvent evaporation method. J Microencapsul. 2001; 18:811-817.
Magharla DD, Sathyamoorthya N, Vankayalu DS, et al. Preparation of poly (epsilon-caprolactone) microspheres containing etoposide by solvent evaporation method. Asian J Pharm Sci. 2010; 5:114-122.
Soni G, Yadav KS. Fast-dissolving films of sumatriptan succinate: factorial design to optimize in vitro dispersion time. J Pharm Innovation. 2015; 10:166-174.
Chakraborty P, Dey S, Parcha V, Bhattacharya SS, Ghosh A. Design expert supported mathematical optimization and predictability study of buccoadhesive pharmaceutical wafers of Loratadine. Biomed Res Int. 2013; 197398.
Daspaul S, Mazumder R, Bhattacharya S, Jha AK. Optimization of polymeric nano drug delivery system using 3(2) full factorial design. Curr Drug Deliv. 2013; 10:394-403.
Piepho HP, Edmondson RN. A tutorial on the statistical analysis of factorial experiments with qualitative and quantitative treatment factor levels. J Agro Crop Sci. 2018; 204:429-455.
Deore BV, Mahajan HS, Deore UV. Development and characterization of sustained release microspheres by quasi emulsion solvent diffusion method. Int J ChemTech Res. 2009; 1:634-642.
Saminathan J, Sankar AS, Anandakumar K, Vetrichelvan T. Simple UV spectrophotometric method for the determination of fluvastatin sodium in bulk and pharmaceutical formulations. E-J Chem. 2009; 6:1233-1239.
Chen W, Palazzo A, Hennink WE, Robbert JK. Effect of particle size on drug loading and release kinetics of gefitinib-loaded PLGA microspheres. Mol Pharm. 2017; 14:459-467.
Patel KS, Patel MB. Preparation and evaluation of chitosan microspheres containing nicorandil. Int J Pharm Investig. 2014; 4:32-37.
Ding C, Bi H, Wang D, Kang M, Tian Z, Zhang Y, Wang H, Zhu T, Ma J. Preparation of chitosan/alginate-ellagic acid sustained-release microspheres and their inhibition of preadipocyte adipogenic differentiation. Curr Pharm Biotechnol. 2019; 20:1213-1222.
Jitendra P, Muzib Y, Misra G. Formulation and evaluation of pulsatile drug delivery of fluvastatin sodium. J Chem Pharm Res. 2016; 8:757-764.
Borgmann SH, Bernardi LS, Rauber GS, Oliveira PR, Campos CE, Monti G, Cuffini SL, Cardoso SG. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates. Pharm Dev Technol. 2013; 18:525-534.
Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 2008; 363:26-39.
Abbas AK, Alhamdany AT. Floating Microspheres of Enalapril Maleate as a Developed Controlled Release Dosage Form: Investigation of the Effect of an Ionotropic Gelation Technique. Turk J Pharm Sci. 2020; 17:159-171.
Mateovic T, Kriznar B, Bogataj M, Mrhar A. The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Microencapsul. 2002; 19:29-36.
Singh D, Dixit VK, Saraf S, Saraf S. Formulation optimization of serratiopeptidase-loaded PLGA microspheres using selected variables. PDA J Pharm Sci Technol. 2009; 63:103-112.
Patel J, Patel D, Raval J. Formulation and evaluation of propranolol hydrochloride-loaded carbopol-934p/ethyl cellulose mucoadhesive microspheres. Iran J Pharm Res. 2010; 9:221-232.
Jeyanthi R, Mehta RC, Thanoo BC, DeLuca PP. Effect of processing parameters on the properties of peptide-containing PLGA microspheres. J Microencapsul. 1997; 14:163-174.
Jelvehgari M, Nokhodchi A, Rezapour M, Valizadeh H. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Indian J Pharm Sci. 2010; 72:72-78.
Yang Y, Gao Y, Mei X. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres. Pharm Dev Technol. 2013; 18:1169-1174.
Ravi S, Peh KK, Darwis Y, Murthy BK, Singh TR, Mallikarjun C. Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system. Ind J Pharm Sci. 2008; 70:303-309.
Aravand, MA and Semsarzadeh, MA. Particle Formation by Emulsion Inversion Method: Effect of the Stirring Speed on Inversion and Formation of Spherical Particles. Macromol Symposia. 2008; 274:141–147.
Busatto C, Pesoa J, Helbling I, Luna J, Estenoz D. Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: Experimental and mathematical modeling. Int J Pharm. 2018; 536:360-369.
Kenechukwu FC, Momoh MA. Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres. Int J Pharm Investig. 2016; 6:69-77.
Published

